Literature DB >> 12107080

Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma.

Akira Seko1, Koji Nagata, Suguru Yonezawa, Katsuko Yamashita.   

Abstract

The content of sulfated glycans having 6-O-sulfated GlcNAc residues alters in the course of colonic carcinogenesis. We previously characterized two GlcNAc 6-O-sulfotransferases (SulTs), SulT-a and -b, expressed in colonic normal tissues and adenocarcinomas [Seko et al. (2000) Glycobiology, 10, 919-929]. Levels of the enzymatic activities of SulT-a in normal colonic mucosa are higher than those in colonic adenocarcinomas, and the enzymatic activities of SulT-b are detected only in mucinous adenocarcinomas. To determine which GlcNAc 6-O-SulTs cloned so far correspond to SulT-a and -b, we expressed seven enzymes of a Gal/GalNAc/GlcNAc 6-O-SulT family in COS-7 cells and examined their substrate specificities in comparison with those of SulT-a and -b. GlcNAc6ST-2 (HEC-GlcNAc6ST, LSST, or GST-3) can recognize GlcNAcbeta1-->3GalNAcalpha1-O-pNP as a good acceptor as well as other O-linked- and N-linked-type oligosaccharides, and its substrate specificity was similar to that of SulT-b. GlcNAc6ST-3(I-GlcNAc6ST or GST-4alpha) preferred Galbeta1-->3(GlcNAcbeta1-->6)GalNAcalpha1-O-pNP as an acceptor to the other oligosaccharides examined, and its specificity was similar to that of SulT-a. To confirm these correspondences, we further performed quantitative analyses of transcripts for GlcNAc6ST-2 and -3 genes by competitive RT-PCR. As a result, GlcNAc6ST-2 gene was expressed in almost all the mucinous adenocarcinomas examined and hardly expressed in normal colonic mucosa and nonmucinous adenocarcinoma. Expression levels of transcript for GlcNAc6ST-3 in normal mucosa were significantly higher than those in adenocarcinomas. From these results, it was indicated that GlcNAc6ST-2 corresponds to mucinous adenocarcinoma-specific SulT-b and that expression of GlcNAc6ST-3 is down-regulated in colonic adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107080     DOI: 10.1093/glycob/12.6.379

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas.

Authors:  Akira Kanoh; Akira Seko; Hiroko Ideo; Midori Yoshida; Mitsuharu Nomoto; Suguru Yonezawa; Masaru Sakamoto; Reiji Kannagi; Katsuko Yamashita
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

2.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

3.  Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis.

Authors:  Shin-Yi Yu; Cheng-Te Hsiao; Mineko Izawa; Akiko Yusa; Hiroji Ishida; Shigeo Nakamura; Hirokazu Yagi; Reiji Kannagi; Kay-Hooi Khoo
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

4.  Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice.

Authors:  Yuki Tobisawa; Yasuyuki Imai; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

5.  Conditional gene targeting in mouse high endothelial venules.

Authors:  Hiroto Kawashima; Jotaro Hirakawa; Yuki Tobisawa; Minoru Fukuda; Yumiko Saga
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancer.

Authors:  Akira Seko; Fumio Kataoka; Daisuke Aoki; Masaru Sakamoto; Toshiaki Nakamura; Masayuki Hatae; Suguru Yonezawa; Katsuko Yamashita
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

7.  Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer.

Authors:  Toshiaki K Shibata; Fumiko Matsumura; Ping Wang; Shinyi Yu; Chi-Chi Chou; Kay-Hooi Khoo; Kazuko Kitayama; Tomoya O Akama; Kazuhiro Sugihara; Naohiro Kanayama; Kyoko Kojima-Aikawa; Peter H Seeberger; Minoru Fukuda; Atsushi Suzuki; Daisuke Aoki; Michiko N Fukuda
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 8.  Heparan Sulfate Proteoglycans in Human Colorectal Cancer.

Authors:  Carolina Meloni Vicente; Daiana Aparecida da Silva; Priscila Veronica Sartorio; Tiago Donizetti Silva; Sarhan Sydney Saad; Helena Bonciani Nader; Nora Manoukian Forones; Leny Toma
Journal:  Anal Cell Pathol (Amst)       Date:  2018-06-20       Impact factor: 2.916

9.  Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors.

Authors:  Longshan Zhang; Yao Fan; Xiaoqing Wang; Mi Yang; XiXi Wu; Weiqiang Huang; Jin Lan; Liwei Liao; Wenqi Huang; Lu Yuan; Hua Pan; Yuting Wu; Longhua Chen; Jian Guan
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

10.  The mRNA-miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma.

Authors:  Bo Hu; Xiaolu Ma; Peiyao Fu; Qiman Sun; Weiguo Tang; Haixiang Sun; Zhangfu Yang; Mincheng Yu; Jian Zhou; Jia Fan; Yang Xu
Journal:  Genomics Proteomics Bioinformatics       Date:  2021-03-17       Impact factor: 6.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.